600521.SH
华海药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 16.20
−2.53%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
29.6x
EV/EBITDA
18.5x
Market Cap
CNY 24.25B
MomentumView details →
1D Return
−2.53%
YTD Return
−5.77%
RSI (14)
41.6
ValuationView details →
P/E (Fwd)
29.6x
EV/EBITDA
18.5x
Market Cap
CNY 24.25B
RSI (14)
41.6
MomentumView details →
1D Return
−2.53%
YTD Return
−5.77%
Similar companies
Latest newsMore news →
Huahai Pharmaceutical reported its first-half 2026 results, with net profit attributable to shareholders of 771 million yuan, up 88.26% year-on-year.9d agoHuahai Pharmaceutical announced that three subsidiaries passed drug GMP compliance inspections, covering products including the IL-36R monoclonal antibody and an API.16d ago